Feasibility trial of a transdiagnostic psychotherapy to improve mental health, resilience and long-term stability: Well-Being Therapy (WBT) as a group intervention in a day-clinic overall treatment concept.

Feasibility trial of a transdiagnostic psychotherapy to improve mental health, resilience and long-term stability: Well-Being Therapy (WBT) as a group intervention in a day-clinic overall treatment concept. - WBT-TK

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00034724

Enrollment

370

Registered

2024-07-25

Start date

2024-08-12

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F30-F39 F20-F29 F60 F61 F62 F40-F48

Interventions

Group 1: Patients with different psychiatric diagnosis (affective disorders, psychotic disorders, anxiety disorders, obsessive-compulsive disorders, neurotic, stress or somatoform disorders, personali

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Participants with sufficient knowledge of German. Patients must meet the diagnostic criteria for one of the following main diagnoses according to ICD10: diagnosis of an affective disorder (F30-F39), a psychotic disorder (F20-F29), an anxiety disorder (F40-F41), an obsessive-compulsive disorder (F42), a neurotic, stress or somatoform disorder (F43-F48) or a personality disorder (F60-F62) and participate in the program of the psychiatric day clinic, Clinic and Polyclinic for Psychiatry and Psychotherapy, University Hospital of Munich, LMU Munich.

Exclusion criteria

Exclusion criteria: Patients are excluded if they meet the ICD10 criteria for active substance dependence (abstinence for less than 6 months), an eating disorder, an organic mental disorder or acute suicidality (as a primary or comorbid diagnosis). Patients are screened and diagnosed by a trained clinician using the ICD10 criteria (mini-interview and SKID-5-PD). All patients are excluded who are currently pregnant or who suffer from an unstable or inadequately treated concomitant somatic disease including acute and chronic infections and autoimmune disease.

Design outcomes

Primary

Measure	Time frame
Naturalistic longitudinal study of the improvement in psychological well-being (WHO-5), euthymia (Euthymia Scale, CIE), resilience (CD-RISC19), quality of life (WHOQOL-BREF) and psychosocial functioning level (SOFAS, PSI) through an 8-week transdiagnostic WBT therapy program in a day hospital setting.	—

Secondary

Measure	Time frame
• Naturalistic longitudinal study of the improvement of mental illness symptoms (BSI-53, MASDR, BDI-II) through an 8-week transdiagnostic WBT therapy program in a day clinic setting. • Naturalistic longitudinal investigation of clinical predictors, mediators and moderators (including childhood trauma: CTQ) of the 8-week transdiagnostic WBT therapy program. • Feasibility and acceptance of WBT: WBT can be used sensibly in the context of a general psychiatric day clinic and is accepted by patients with various mental illnesses as well as by employees.	—

Measure

Time frame

• Naturalistic longitudinal study of the improvement of mental illness symptoms (BSI-53, MASDR, BDI-II) through an 8-week transdiagnostic WBT therapy program in a day clinic setting. • Naturalistic longitudinal investigation of clinical predictors, mediators and moderators (including childhood trauma: CTQ) of the 8-week transdiagnostic WBT therapy program. • Feasibility and acceptance of WBT: WBT can be used sensibly in the context of a general psychiatric day clinic and is accepted by patients with various mental illnesses as well as by employees.

—

Countries

Germany

Contacts

Public ContactAndrea Jobst-Heel

LMU Klinikum, Klinik für Psychiatrie und Psychotherapie

A.Jobst@med.uni-muenchen.de+0049 89 4400 55881

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026